| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $2.1M | -42.8% | -68.9% |
| SG&A Expense | $1.9M | -19.2% | +18.3% |
| Operating Income | -$4.0M | +33.6% | +52.4% |
| Pre-tax Income | -$4.0M | +33.7% | +52.1% |
| Income Tax | $3K | -64.3% | — |
| Net Income | -$4.0M | +33.7% | +52.1% |
| EPS (Basic) | -$0.06 |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $13.2M | +27.2% | +137.2% |
| Current Assets | $13.5M | +24.9% | +98.4% |
| Total Assets | $14.3M | +23.2% | +87.8% |
| Current Liabilities | $9.7M | -19.4% | -44.5% |
| Total Liabilities | $9.8M | -19.1% | -44.5% |
| Stockholders' Equity |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$18.8M | — | — |
| Financing Cash Flow | $18.5M | — | — |
| +50.0% |
| +76.0% |
| $4.5M |
| +1090.9% |
| +145.6% |